|[October 11, 2013]
Bracco Diagnostics Inc. Makes New Syringe Packs Available for Use with EmpowerCTA® Computed Tomography Contrast Delivery Systems
MONROE TOWNSHIP, N.J. --(Business Wire)--
Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A,
recently announced the availability of syringe packs with spikes, to be
used when loading contrast and saline for delivery with power injectors
in computed tomography (CT) suites.
Bracco syringe packs are specifically designed for use with the
EmpowerCTA and Empower CT contrast delivery systems, offering greater
flexibility in contrast and saline preparation. According to Terry
Heagy, Senior Device Business Manager, Bracco Diagnostics Inc., "These
new syringe packs reduce opportunities for contamination, help reduce
contrast mess and allow efficient contrast loading." Heagy also noted
that the new spikes work with all volumes of contrast and saline to
promote workflow efficiencies and ease of use. In addition, Bracco
syringe packs with spikes conform to the Joint Commission's "Elements of
Performance for Medication Management," as it pertains to standards for
hospitals safely preparing medications.*
The EmpowerCTA Contrast Injection System is a dual head injector,
designed to optimize the delivery of iodinated X-ray contrast media and
saline flush in the dual head configuration during computed tomography
(CT) procedures. The EmpowerCTA Contrast Injection System is rated among
the safest injectors in the industry and is used in major teaching
institutions in the United States. The EmpowerCTA has a built-in
estimated Glomerular Filtration Rate (eGFR) calculator and a fully
integrated Extravasation Detection Accessory (EDA™).
Not all products are available in all global markets. Please refer to
your local distributor or agent.
EmpowerCTA is designed for the vascular administration of contrast and
flushing media in conjunction with computed tomography (CT) scanning of
the body. The EDA is intended to detect extravasations of contrast media
during powered CT contrast injections.
EmpowerCTA and EmpowerCT are registered trademarks of Bracco Injeneering
SA, registered in the United States.
EDA is a registered trademark of Bracco Injeneering SA, registered in
the United States.
Bracco Diagnostics Inc., reserves the right to modify the specifications
and features described herein, or discontinue manufacture of the product
described at any time without prior notice or obligation.
Please contact your authorized Bracco Injeneering SA representative for
the most updated information.
For additional information about Bracco's products, and for full
prescribing information, please visit http://imaging.bracco.com/us-en.
If you have any questions or require additional information about any
Bracco product, please contact Bracco Professional Services at
1-800-257-5181, option 2.
About Bracco Imaging
Bracco Imaging S.p.A., part of the Bracco Group, is one of the world's
leading companies in the diagnostic imaging business. Headquartered in
Milan, Italy, Bracco Imaging develops, manufactures and markets
diagnostic imaging agents and solutions that meet medical needs.
Bracco Imaging offers a product and solution portfolio for all key
diagnostic imaging modalities: X-Ray Imaging (including Computed
Tomography-CT, Interventional Radiology, and Cardiac Catheterization),
Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS),
Nuclear Medicine through radioactive tracers, and Gastrointestinal
Endoscopy. The diagnostic imaging offer is completed by several medical
devices and advanced administration systems for contrast imaging
products in the fields of radiology.
The Company operates in over 90 markets worldwide, either directly or
indirectly, through subsidiaries, joint ventures, licenses and
distribution partnership agreements. With an on-going research covering
all key modalities, Bracco Imaging has a strong presence in key
geographies: North America; Europe and Japan operating through the Joint
Venture Bracco-Eisai Co., Ltd. The Company also operates in Brazil,
South Korea, and China through the Joint Venture Bracco Sine
Pharmaceutical Corp. Ltd.
Operational investments have been made in order to achieve top quality
and compliance with a sustainable eco-friendly production. Manufacturing
activities are located in Italy, Switzerland, Japan, China and Germany.
Bracco Imaging is an innovative Research and Development (R&D) player
with an efficient process oriented approach and a track record of
innovation in the diagnostic imaging industry. R&D activities are
managed in the three Research Centres located in Italy, Switzerland and
For additional information - Please Contact Kai Huang, Product
- +1 (609) 514-2396.
*Joint Commission 2013, Standard MM.05.01.07 - The hospital safely
[ Back To Technology News's Homepage ]